Form 4: Akoya Biosciences Executive Niro Ramachandran Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Niro Ramachandran, Chief Business Officer of Akoya Biosciences, disposed of 2,310 shares to cover taxes related to a restricted stock unit award.
Summary
- On March 23, 2025, Niro Ramachandran, the Chief Business Officer of Akoya Biosciences, Inc., disposed of 2,310 shares of common stock.
- The transaction was executed to cover tax obligations related to a restricted stock unit award previously granted on March 23, 2022.
- The shares were withheld at a price of $1.7.
- Following the transaction, Ramachandran directly owns 287,210 shares of Akoya Biosciences.
Sentiment
Score: 5
Explanation: This is a neutral event. It reflects routine tax management related to executive compensation.
Industry Context
This is a routine Form 4 filing related to insider transactions. It is common for executives to dispose of shares to cover tax obligations related to vesting equity awards.
Stakeholder Impact
- The transaction has minimal impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/23/2022 | Date of original restricted stock unit award grant |
| 03/23/2023 | First vesting date of the restricted stock unit award |
| 03/23/2025 | Date of transaction (share disposal for tax withholding) |
| 03/25/2025 | Date of signature |
Keywords
Akoya Biosciences, Niro Ramachandran, Form 4, Insider Trading, Stock Disposal, Tax Withholding, Restricted Stock Units, AKYA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.